Topoisomerase 2 alpha cooperates with androgen receptor to contribute to prostate cancer progression

J. L. Schaefer-Klein, Stephen J. Murphy, Sarah H. Johnson, George Vasmatzis, Irina V. Kovtun

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


Overexpression of TOP2A is associated with risk of systemic progression in prostate cancer patients, and higher levels of TOP2A were found in hormone-resistant cases. To elucidate the mechanism by which high levels of TOP2A contribute to tumor progression we generated TOP2A overexpressing prostate cancer cell lines. We show that TOP2A promotes tumor aggressiveness by inducing chromosomal rearrangements of genes that contribute to a more invasive phenotype. Anti-androgen treatment alone was ineffective in killing TOP2A overexpressing cells due to activation of an androgen receptor network. TOP2A poisons killed tumor cells more efficiently early in the progression course, while at later stages they provided greater benefit when combined with anti-androgen therapy. Mechanistically, we find that TOP2A enhances androgen signaling by facilitating transcription of androgen responsive genes, thereby promoting tumor cell growth.

Original languageEnglish (US)
Article numbere0142327
JournalPloS one
Issue number11
StatePublished - Nov 1 2015

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General


Dive into the research topics of 'Topoisomerase 2 alpha cooperates with androgen receptor to contribute to prostate cancer progression'. Together they form a unique fingerprint.

Cite this